ImmunityBio (26CA.F) Q4 2023 Earnings

19MarConfirmed
Q4 2023
-0.33
-0.28
-0.22
-0.17

Details

Expected EPS
-0.1657116
Actual EPS
-0.3314232
Surprise EPS
-0.17
Surprise Percent
+100%

Description

ImmunityBio (26CA.F) has reported earnings of -0.3314232 per share for Q4 2023.

0 Comments

Share your thoughts